| http://www.w3.org/ns/prov#value | - pdatesUpdates all GSK and GSK-partnered product lines from Arzerra and Benlysta to Pandemrix and Relenza, cast against the backdrop of clinical trial results, approvals and post-market study outcomesDiscusses critical strategies by GSK into emerging markets such as Jordan, Syria, Libya, Yemen and India, as well as their successes and ongoing issuesDelivers a general company overview, including sta
|
